Template:Hemolytic anemia DDX: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
|||
| Line 8: | Line 8: | ||
*[[Paroxysmal nocturnal hemoglobinuria]] (PNH) | *[[Paroxysmal nocturnal hemoglobinuria]] (PNH) | ||
*[[Malignant hypertension]] | *[[Malignant hypertension]] | ||
*[[Scleroderma]] | *[[Scleroderma]] | ||
*[[Antiphospholipid Syndrome (APS)]] | *[[Antiphospholipid Syndrome (APS)]] | ||
Latest revision as of 19:21, 12 May 2019
Microangiopathic Hemolytic Anemia (MAHA)
- Disseminated Intravascular Coagulation (DIC)
- Thrombotic Thrombocytopenic Purpura (TTP)
- Hemolytic Uremic Syndrome (HUS)
- HELLP syndrome
- Heparin-Induced Thrombocytopenia (HIT)
- Hereditary spherocytosis
- Paroxysmal nocturnal hemoglobinuria (PNH)
- Malignant hypertension
- Scleroderma
- Antiphospholipid Syndrome (APS)
- Other medical causes: malignancy, renal allograft rejection, vasculitides like polyarteritis nodosa and Wegener's granulomatosis
- Drugs: chemotherapy; Clopidogrel (Plavix) associated with TTP
- Nonvascular causes: prosthetic valve (more common with mechanical, more common at aortic valve), LVAD, TIPS, coil embolization, patched AV shunt, AVM